Journal of Neurogastroenterology and Motility · 2020 · 32 citations · 31 references
MedicineClinical SciencesPharmacotherapyGastroenterologyGastrointestinal PharmacotherapyEsophageal DiseasesFunctional Gastrointestinal DisordersGastroesophageal Reflux DiseaseGastrointestinal InterventionsGastrointestinal PathophysiologyGastrointestinal PharmacologyGastroesophageal Reflux Disease PharmacotherapyGastroesophageal Reflux EvaluationGastroesophageal Reflux PathophysiologyHigh-resolution ManometryProton Pump InhibitionReflux Esophagitis
Background/Aims: Impaired esophageal motility and disrupted esophagogastric junction (EGJ) on high-resolution manometry (HRM) have been associated with increased reflux severity in gastroesophageal reflux disease (GERD) patients. However, there are limited data evaluating HRM parameters in proton pump inhibitors (PPI) non-responders. Methods: Clinical and endoscopic data, HRM and multichannel intraluminal impedance-pH studies performed of PPI therapy in patients with typical GERD symptoms were reviewed from 3 international centers. Frequency of GERD symptoms was assessed on and off PPI therapy in both non-responders (< 50% symptom improvement on PPI therapy) and responders. Rome IV definitions identified non-erosive reflux disease, reflux hypersensitivity, and functional heartburn. Univariate and multivariate analyses were performed to determine predictors of non-response. Results: = 0.044) were associated with an unfavorable response to PPIs. Conclusions: Intact EGJ metrics on HRM complement normal reflux burden in predicting non-response to PPI therapy. HRM has value in the evaluation of PPI non-responders.
31